Literature DB >> 11935310

Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas: a quantitative analysis.

E Hrabec1, M Strek, D Nowak, J Greger, M Suwalski, Z Hrabec.   

Abstract

PURPOSE: Matrix metalloproteinases MMP-2 and MMP-9 are implicated in invasion and metastasis of malignant tumors. We investigated the expression and activation of MMP-2 and MMP-9 in lung cancer compared with normal lung parenchyma, and looked for a potential marker of malignancy.
METHODS: Thirty-six pulmonary carcinomas and paired normal lung specimens were analyzed by gelatin zymography and computer-assisted image analysis for the expression of MMP-2 and MMP-9.
RESULTS: We showed that expression of both type IV collagenases was remarkably higher in carcinoma samples than in lung parenchyma. The MMP-9 levels in lung cancer were over twofold higher than in normal lung tissues. The levels of latent and active forms of MMP-2 in lung cancer samples were, correspondingly, 3.8- and 17-fold higher than in lung parenchyma. The tumor/normal (T/N) ratios of MMP-2 were negatively correlated with the hemoglobin levels and erythrocytes number.
CONCLUSIONS: A high level of the active form of MMP-2 in almost all of the carcinomas and the near lack of its activation in normal lung parenchyma shows that MMP-2 activation is associated with the malignant phenotype and may serve as a good marker of malignancy. The correlation between low hemoglobin level and T/N ratio of MMP-2 may indicate significance of MMP-2 for angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11935310     DOI: 10.1007/s00432-001-0320-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  13 in total

1.  Inhibitory effect of chitooligosaccharides on matrix metalloproteinase-9 in human fibrosarcoma cells (HT1080).

Authors:  Quang Van Ta; Moon-Moo Kim; Se-Kwon Kim
Journal:  Mar Biotechnol (NY)       Date:  2006-11-08       Impact factor: 3.619

2.  Berberine hydrochloride inhibits cell proliferation and promotes apoptosis of non-small cell lung cancer via the suppression of the MMP2 and Bcl-2/Bax signaling pathways.

Authors:  Jie Li; Fang Liu; Shulong Jiang; Jie Liu; Xiuhong Chen; Shangnuan Zhang; Haibo Zhao
Journal:  Oncol Lett       Date:  2018-03-13       Impact factor: 2.967

3.  A Fra-1-dependent, matrix metalloproteinase driven EGFR activation promotes human lung epithelial cell motility and invasion.

Authors:  Pavan Adiseshaiah; Michelle Vaz; Narsa Machireddy; Dhananjaya V Kalvakolanu; Sekhar P Reddy
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

Review 4.  Meta-analysis of association of the matrix metalloproteinase 2 (-735 C/T) polymorphism with cancer risk.

Authors:  Su Kang Kim; Sang Wook Kang; Hae Jeong Park; Ju Yeon Ban; Chung-Hun Oh; Joo-Ho Chung; In-Hwan Oh; Kyu Bong Cho; Min-Su Park
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Active MMP-2 effectively identifies the presence of colorectal cancer.

Authors:  Mary Jo Murnane; Jinguo Cai; Sania Shuja; David McAneny; Veronica Klepeis; John B Willett
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

6.  Serum metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in lung carcinoma patients.

Authors:  Magdalena Drzewiecka-Jędrzejczyk; Rafał Wlazeł; Monika Terlecka; Sławomir Jabłoński
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

7.  Intraocular matrix metalloproteinase 2 and 9 in patients with diabetes mellitus with and without diabetic retinopathy.

Authors:  Anna B Kłysik; Julia Naduk-Kik; Zbigniew Hrabec; Roman Goś; Elżbieta Hrabec
Journal:  Arch Med Sci       Date:  2010-06-30       Impact factor: 3.318

8.  Effects of 5-aza-2'deoxycytidine on RECK gene expression and tumor invasion in salivary adenoid cystic carcinoma.

Authors:  X Q Zhou; S Y Huang; D S Zhang; S Z Zhang; W G Li; Z W Chen; H W Wu
Journal:  Braz J Med Biol Res       Date:  2014-12-12       Impact factor: 2.590

9.  Systemic delivery of protein nanocages bearing CTT peptides for enhanced imaging of MMP-2 expression in metastatic tumor models.

Authors:  Takahito Kawano; Masaharu Murata; Jing Shu Piao; Sayoko Narahara; Nobuhito Hamano; Jeong-Hun Kang; Makoto Hashizume
Journal:  Int J Mol Sci       Date:  2014-12-24       Impact factor: 5.923

10.  Hinokitiol Inhibits Migration of A549 Lung Cancer Cells via Suppression of MMPs and Induction of Antioxidant Enzymes and Apoptosis.

Authors:  Thanasekaran Jayakumar; Chao-Hong Liu; Guan-Yi Wu; Tzu-Yin Lee; Manjunath Manubolu; Cheng-Ying Hsieh; Chih-Hao Yang; Joen-Rong Sheu
Journal:  Int J Mol Sci       Date:  2018-03-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.